News
-
-
-
-
-
PRESS RELEASE
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
Tharimmune, Inc. appoints James Gordon Liddy as strategic advisor for TH104 development, targeting high-potency opioid exposure. FDA feedback positive for prophylaxis indication -
PRESS RELEASE
Interactive Strength Inc. (Nasdaq: TRNR) Reports First Quarter 2025 Results, Increases 2025 Pro Forma Revenue Guidance to more than $75M
Interactive Strength Inc. reports Q1 revenue of $1.4M with improved adjusted EBITDA loss and higher pro forma guidance. Stockholders' equity reaches $13.8M -
-
-
-
